Amyloidosis is a diverse group of diseases involving the deposition of abnormal proteins, with TTR amyloidosis being a significant cause of cardiac involvement.
186 patients suspected of cardiac amyloidosis were retrospectively analyzed, revealing 27.4% positive results in 99mTc-DPD scintigraphy and several demographic insights into the diagnosed cases.
Nuclear medicine is vital for diagnosing and classifying cardiac amyloidosis, but consistent monitoring and testing remain insufficient.